Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mark Boguniewicz

7PUBLICATIONS

41CO-AUTHORS

Environmental epidemiologyInfant and child healthAdolescent healthPsychology of ageingAllergy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 02, 2025

Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis.

Eric L Simpson, Jonathan I Silverberg, Vimal H Prajapati

|Feb 21, 2025

Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial.

Lawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati

|Nov 15, 2024

Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies.

Eric L Simpson, Matthias Augustin, Diamant Thaçi

|Oct 29, 2024

Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.

Mark Boguniewicz, Lawrence D Sher, Amy S Paller

|Oct 21, 2022

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials.

Jonathan I Silverberg, Mark Boguniewicz, Jon Hanifin

|Jul 11, 2022

Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis.

Evgeny Berdyshev, Elena Goleva, Robert Bissonnette

Pageof 2

Frequent Collaborators

3 joint publications

Jonathan I Silverberg

3 joint publications

Erin Almaraz

2 joint publications

Vimal H Prajapati

2 joint publications

Kim A Papp

2 joint publications

Ana B Rossi

1 joint publications

D J Margolis

1 joint publications

L Fonacier

1 joint publications

P Y Ong

1 joint publications

Z C Chiesa Fuxench

1 joint publications

J M Gelfand

Frequent Collaborators

3 joint publications

Jonathan I Silverberg

3 joint publications

Erin Almaraz

2 joint publications

Vimal H Prajapati

2 joint publications

Kim A Papp

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on : Jul 03, 2025

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Published on : Jan 19, 2024

See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on : Jul 03, 2025

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

Published on : Jan 19, 2024

See more related videos